Viewing Study NCT01852266


Ignite Creation Date: 2025-12-24 @ 4:30 PM
Ignite Modification Date: 2026-03-01 @ 3:23 PM
Study NCT ID: NCT01852266
Status: COMPLETED
Last Update Posted: 2016-09-15
First Post: 2013-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module